New US patent approval for Episurf Medical
Episurf Medical (NASDAQ: EPIS B) has received another Notice of Allowance from the United States Patent and Trademark Office (USPTO). The patent, entitled “A method for manufacturing an implant and an implant with two coatings”, is in the area of implant materials and coating characteristics related to Episurf Medical’s devices. “Increased patent protection to support our research and development work is much appreciated, especially in the US market for which we have multiple products in the pipeline” comments Katarina Flodström, COO, Episurf Medical.